122 results on '"Del Toro G"'
Search Results
2. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
3. Medicion de pH y cuantificacion de metales pesados en los lixiviados del relleno sanitario mas grande de la zona metropolitana de la ciudad de Mexico
4. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients
5. Estudio espectrofotometrico de la actividad hemolitica del 3-hidroxibenzaldehido y el 4-hidroxibenzaldehido en eritrocitos
6. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases
7. Outcomes of unrelated cord blood transplantation in pediatric recipients
8. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases
9. Morphology and mycelial growth rate of Pleurotus spp. strains from the Mexican mixtec region
10. Moyamoya Syndrome Treated with Encephaloduroarteriosynangiosis Followed by Hematopoietic Cell Transplantation in Patients with Sickle Cell Disease
11. Moyamoya Syndrome Treated With Encephaloduroarteriosynangiosis Followed by Bone Marrow Transplantation in a Patient With Sickle Cell Disease: A Case Report
12. O9 First report of hematopoietic cell transplantation for sickle cell disease from in-vitro fertilization-selected donor
13. A Study Of The Barriers Preventing Access Of U.S. Pediatric Sickle Cell Disease Patients To Technologies That Facilitate Compatible Sibling Hematopoietic Cell Transplantation
14. Intra-Arterial Steroids For Systemic Steroid Resistant Graft-Vs-Host Disease
15. Antibacterial activity of Pleurotus spp. hexanic extracts
16. α4β2 Receptors of ventral hippocampus and memory consolidation
17. 212: Adenovirus (ADV) infections following allogeneic stem cell transplant (alloSCT) in children and adolescent recepients
18. 185: Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma
19. 3: Reduced Intensity (RI) aLlogeneic Cord Blood Hematopoietic Cell Transplantation (Allo-CBHCT) in Pediatric Patients with Malignant and Non-Malignant Diseases
20. Reduced intensity (RI) allogeneic cord blood hematopoietic cell transplantation (Allo CBHCT) in pediatric patients with malignant and non-malignant diseases
21. High-performance liquid chromatography-mass spectrometric analysis of alkaloids extracted from seeds ofErythrina herbacea
22. Reduced intensity conditioning and allogeneic stem cell transplantation (RI AlloSCT) in children and adolescents with malignancies following unrelated cord blood and matched family donor AlloSCT results in ≥90% achieving ≥98% donor chimerism
23. Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in pediatric allogeneic SCT (AlloSCT) recipients: altered MMF pharmacokinetics (pk) associated with acute (A)GVHD
24. A pilot study of myeloablative (MA) autologous stem cell transplantation (AUTOSCT) followed by reduced intensity (RI) allogeneic transplantation (ALLOSCT) in children and young adults with relapsed/refractory lymphoma
25. Reduced intensity conditioning and allogeneic stem cell transplantation (RIAlloSCT) from unrelated cord blood and matched family donors in children and adolescent recipients results in sustained donor chimerism
26. 120Unrelated cord blood transplantation (UCBT) from HLA disparate donors results in a very low risk of ≥grade II acute & chronic GVHD: CD34 dose and non-TBI conditioning predict for significantly improved survival
27. Hydrogen interactions and catalytic properties of platinum-tin supported on zinc aluminate
28. High-performance liquid chromatography-mass spectrometric analysis of alkaloids extracted from seeds of Erythrina herbacea.
29. Estudio espectrofotométrico de la actividad hemolítica del 3-hidroxibenzaldehído y el 4-hidroxibenzaldehído en eritrocitos.
30. Alternate day ganciclovir and foscarnet is safe and effective in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients
31. A pilot study of myeloablative (MA) autologous stem cell (autoSCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children and adolescents with relapsed hodgkin’s disease (HD) and non-hodgkin’s lymphoma (NHL)
32. Higher clearance rates of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (allosct) recipients
33. Sequential administration of sargramostim (GM-CSF) and filgrastim (G-CSF) in pediatric allogeneic stem cell transplant (allosct) recipients undergoing myeloablative (MA) conditioning: Cost-effective and more rapid platelet recovery in UCB recipients
34. Viability kinetics of free and immobilized bifidobacterium bifidum in presence of food samples under gastrointestinal in vitro conditions | Cinéticas de viabilidad de bifidobacterium bifidum libre e inmovilizado en presencia de muestras alimenticias bajo condiciones gastrointestinales in vitro
35. 253Alternate day ganciclovir/foscarnet (Gan/Fos) for cytomegalovirus prophylaxis in at risk allogeneic stem cell transplant related and unrelated recipients is 100% effective in preventing CMV infections
36. 205Non-myeloablative allogenic stem cell transplant (NASCT) with unrelated cord blood and matched family donors in children and adolescents
37. 197A pilot study of myeloablative (MA) autologous stem cell transplantation (Auto SCT) followed by reduced intensity (RI) allogeneic transplantation (ALLO SCT) in children and young adults with relapsed lymphoma
38. 94 Tacrolimus (FK-506) and mycophenolate mofetil (MMF) GVHD prophylaxis in allogeneic SCT (alloSCT) recipients: Altered MMF pharmacokinetics (PK) associated with AGVHD
39. 185: Feasibility of autologous stem cell transplant followed by reduced intensity allogeneic stem cell transplantation for high risk neuroblastoma A single institution pilot study
40. Defibrotide in sinusoidal obstruction syndrome: mounting evidence in pediatric patients (Commentary on Qureshi et al., page 831)
41. First report of hematopoietic cell transplantation for sickle cell disease from in-vitro fertilization-selected donor.
42. Caracterización de los buffer fosfatos utilizados en la preparación de solución de hemoglobina (Hb) a pH controlado.
43. ETHANOL PRODUCTION USING LIGNOCELLULOSIC BIOMASS.
44. A novel coconut-malt extract medium increases growth rate of morels in pure culture.
45. Functional properties of flours and protein concentrates of 3 strains of the edible mushroom Pleurotus ostreatus .
46. [Use of ITS and ISSR markers in the molecular characterisation of Pleurotus djamor hybrid strains].
47. Spasmolytic effect of Alternanthera repens on isolated rat ileum.
48. Biological activity of liposomal vanillin.
49. Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.
50. An unusual case of donor-derived myelodysplastic syndrome following double-unit umbilical cord blood transplantation in acute lymphoblastic leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.